by Shi-qi An | Jan 2, 2025 | News
A warm welcome to our new board members, Dr Oliver Hardick of M Ventures and Chris Major of BioProcess 360 Partners. Oliver is Entrepreneur in Residence in the Biotechnology team at M Ventures, with a focus on life science tools & technology innovation. Having...
by Shi-qi An | Dec 4, 2024 | News
Series A financing highlights the potential impact of Abselion’s technology for life science research and bioprocess development Abselion, an innovator in automated analytical instrumentation that simplifies at-line protein quantification, has secured £6.6 million in...
by Shi-qi An | Sep 17, 2024 | News
Abselion is delighted to announce the appointment of Dr Anne Jones to the board of the company as non-executive director. Anne brings over 25 years of global commercial experience in the Life Sciences, Healthcare and Cell Therapy arenas working with world class...
by Shi-qi An | Aug 20, 2024 | News
Collaborative Project to Develop Next-Generation Cell Platform for Viral Vector Manufacturing Receives £1.1 Million Grant from Innovate UK & NRC Cambridge (UK) & Montreal (Canada), August 20th 2024 In a ground-breaking collaboration, leading biotechnology...
by Shi-qi An | Dec 8, 2023 | News
Abselion is celebrating a significant achievement winning the coveted Bioprocessing Industry Association 2023 award for Next-Gen Analytics at the annual industry gathering. This recognition comes in light of Amperia, a groundbreaking benchtop tool designed to...
